Clinical Trials Logo
  1. Home
  2. Liver Fibrosis
  3. NCT03770936
  4. Details
NCT03770936 Clinical Trial

Effect of Some Drugs on Liver Fibrosis

Liver Fibroses Clinical Trial

Official title:
Clinical Study Evaluating the Efficacy of Renin Angiotensin System Inhibitors on the Extent of Liver Fibrosis in Patients With Chronic Hepatitis C

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03770936
Other study ID # liver fibrosis
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date October 1, 2018
Est. completion date November 2027

Study information
Verified date December 2018
Source Tanta University
Contact Sherief Abd-Elsalam, Ph D
Phone 00201147773440
Email sheriefabdelsalam@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Effect of Some Drugs on Liver Fibrosis

Description:

The study aimed at evaluating the effect of Some Drugs on Liver Fibrosis

Recruitment information / eligibility
Status Recruiting
Enrollment 45
Est. completion date November 2027
Est. primary completion date October 2026
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

- chronic hepatitis C

Exclusion Criteria:

- Acute hepatitis

- Thalassemia

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Candesartan
Candesartan 8 mg/day
• Ramipril
ramipril 1.25 mg/day

Locations
Country Name City State
Egypt Sherief Abd-Elsalam Tanta

Sponsors (1)
Lead Sponsor Collaborator
Sherief Abd-Elsalam

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in Fibroscan or APRI score Change in Fibroscan or APRI score 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04666402 - Integrated Diagnostics for Early Diagnosis of Liver Disease
Active, not recruiting NCT04682600 - The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF N/A
Active, not recruiting NCT03018990 - Alcohol Challenge On Liver and Gut Measured by Liver Vein Catheterization. A Pathophysiological Intervention Trial N/A
Recruiting NCT04155398 - EUS Elastography for Predicting Cirrhotic-related Complications
Completed NCT02967198 - Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using CT or MR/US Fusing Imaging N/A
Recruiting NCT04036357 - Liver Damage and Cardiometabolic Disorders in NAFLD
Recruiting NCT04820036 - A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) N/A
Completed NCT03047707 - S-Shearwave Elastography for Assessment of Hepatic Fibrosis N/A
Recruiting NCT04389593 - Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference
Recruiting NCT05028829 - Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk Phase 2
Completed NCT03149627 - Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults
Withdrawn NCT03598283 - Liver, Pancreas and Thyroid Function in Burn Patients
Completed NCT03389152 - SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases
Completed NCT04115046 - The EUS ShearWave Elastography Liver Fibrosis Study
Completed NCT04579874 - Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. N/A
Terminated NCT03027700 - Methods to Detect Liver Fibrosis N/A
Recruiting NCT04785937 - Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients N/A
Completed NCT04277819 - The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management
Completed NCT03531593 - Dose Effect Relationship of MTX and IBD
Completed NCT04677101 - Liquid Biopsy for NASH and Liver Fibrosis